In terms of nonpharmacologic therapies, cognitive stimulation therapy has been shown to be

cost-effective for people with mild-to-moderate dementia when delivered biweekly over
seven weeks, though was found to have modest effects when continued for longer when
added to administration of acetylcholinesterase inhibitors (D’Amico et al, 2015). An exercise
intervention was found to have the potential to be cost effective when considering
behavioral and psychological symptoms
• but did not appear cost effective when considering quality-adjusted
life year gains. The START (Strategies for Relatives) study, a
randomized controlled trial to determine the clinical effectiveness and
cost-effectiveness of a manual-based coping strategy program in
promoting the mental health of carers of people with dementia,
found the intervention to be cost effective with respect to the
caregiver and patient outcomes, and National Institute for Health and
Care Excellence (NICE) thresholds (Livingston et al, 2014). In a health
economic analysis of resource costs and costs of formal care on a
psychosocial intervention for family caregivers of persons with
dementia, those in the intervention group reported a higher quality of
life while their spouse was living at home (Dahlrup et al, 2014).